Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
about
Prognostic indicators in centroblastic-centrocytic lymphoma.Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group.Multiparametric immunophenotyping of B cells in peripheral blood of healthy adults by flow cytometry.Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphologyFludarabine phosphate for the treatment of low grade lymphoid malignancyDNA content and prognosis of non-Hodgkin's lymphoma.Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosisMinichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphomaNew approaches to the treatment of follicular lymphoma.DNA flow cytometry of follicular non-Hodgkin's lymphoma.Topoisomerase II alpha mRNA and tumour cell proliferation in non-Hodgkin's lymphoma.Nucleolar organiser regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation.Hodgkin's disease in northern Sweden 1971-1981. I. A histopathological reevaluation of 223 cases.Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trialsPrognostication of diffuse large B-cell lymphoma in the rituximab era.Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.B-cell lymphoma of large multilobated type: an immunohistochemical study of 8 cases and review of the literature.Non-Hodgkin's lymphoma in northern Sweden. Prognostic factors and response to treatment.Is the working formulation adequate for the classification of the low grade lymphomas?Cell kinetic analysis of non-Hodgkin's lymphomas using in vivo iododeoxyuridine incorporation and flow cytometry.Lymphoplasmacytoid lymphoma: an immunohistological study.AgNORs predictive value of prognosis in non-Hodgkin's lymphoma: comparison with flow cytometric cell cycle analysis.Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?CD30 expression in non-Hodgkin's lymphoma.High-grade non-Hodgkin's lymphoma of B-cell type. I. Histopathology.Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis.Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.Correlation of morphology, immunophenotype, and flow cytometry with remission induction and survival in high grade non-Hodgkin's lymphoma.Multilobated non-Hodgkin's lymphoma. A clinicopathologic entity.Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.[Significance of clinical and laboratory chemical parameters for the course and prognosis of non-Hodgkin's lymphomas].Long-term follow-up of CHOP-treated non-Hodgkin lymphoma of high-grade malignancy.Remission duration: an example of interval-censored observations.B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomas.HIV-related malignant lymphomas. A clinical and pathological study of 13 cases.Repp86: a new prognostic marker in mantle cell lymphoma.Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphoma.
P2860
Q33839385-85631BD6-195E-46E1-B6A9-068513BD1AF2Q33947282-1938F54D-12ED-4F92-A121-276D96AF3E39Q35225358-3EF1066C-19CE-42C7-8C80-8BFBC5533F22Q35818386-14E972F8-F61D-40F6-B5F5-0DC3A2CA2ED2Q35856207-F0857C0E-DDE3-4D0A-9E50-A898D7634AA4Q35992762-C9FDCE9E-C755-4B2C-A203-8A02405B6513Q36027430-0371374C-7110-4EFF-AD6B-B12B93B5669BQ36028822-DB401174-AC3F-443D-8F30-89288FCC955FQ36615459-310CE3FD-D6D6-4AA4-9464-9284F35AF914Q36704163-3766F61C-5864-43A0-AF07-B7D722E9ACBBQ37143942-1CF4C4DF-CCF1-406D-8855-9ECB3F526B75Q37202012-6A436C21-E199-4199-BA2E-189D758BE70EQ37242544-BFBFA4BE-6764-4E42-B106-6EEE846DEABAQ37300546-A5D53328-216F-46D0-BA63-A23E5E669899Q37406798-FA952502-A341-4627-8CB8-3167EC07755AQ37833087-E2F0E1EA-4598-40D6-987E-0C46B6C537DBQ38678575-81F33EDF-2CA7-408C-BE72-4F91343830CDQ40668694-59867620-EF74-4E3D-B641-E04D8145C5C5Q40770019-ABC87184-4980-46E4-94C2-BD0D959D4BACQ40901594-BB7465BC-65B4-4465-A75D-5B79B1CF7848Q40981490-B8DC6B82-3597-4D13-A5FA-1308D1474026Q41857821-D295F358-7942-4F7A-9F5D-4359AC83DAABQ42155723-13410B9D-769B-49FD-BBEA-031B642A74EBQ42382346-7F644B89-110A-4468-A9CA-2C10A091D39CQ43552008-41DFB6C1-DCAF-43ED-89AA-DFD6D6334446Q43867956-CD32DE7A-300D-4A3A-B07A-E0EF250A57F2Q44129049-8166F48C-182A-4CDD-A5A6-FEDDE6ED3336Q44135718-8A6EC4D5-F566-4EFD-AA39-DE3E637F0706Q44195465-F0859CE1-3C3A-42C4-A189-77560C4BE949Q44528909-C78D5A89-6078-48A7-AA1B-717ACBE634A2Q44872965-04D28BB2-F092-4B10-A555-D96626586203Q44958114-F5497032-D0E9-48C0-8624-0D78F2E87A63Q45308575-8C4484EB-35CB-470C-B196-E1DEA238F9F4Q52550087-C08070FB-9288-4953-99F7-2AA68EFF7CF2Q52584732-A0669EAD-3A65-423C-99F2-07CF84E69F4DQ52596427-31C34E5C-E525-4A5D-B7AA-DCFE5B0E8D91Q53041703-3C4F806B-8E8F-4D25-B750-57B3037CB4E4Q53647104-15D3C4AE-29BB-4E76-8D7B-8978EC70C0C8Q54050685-903499E6-B264-4F0D-874A-18D55E32D7F3
P2860
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Clinical and prognostic releva ...... the Kiel Lymphoma Study Group.
@en
type
label
Clinical and prognostic releva ...... the Kiel Lymphoma Study Group.
@en
prefLabel
Clinical and prognostic releva ...... the Kiel Lymphoma Study Group.
@en
P2093
P2860
P356
P1476
Clinical and prognostic releva ...... the Kiel Lymphoma Study Group.
@en
P2093
Brittinger G
P2860
P304
P356
10.1002/HON.2900020306
P577
1984-07-01T00:00:00Z